Dr Paul Janssen founded Janssen Pharmaceutica in 1953. From the very beginning, his focus was on pharmacological research, which distinguished him from other pharmaceutical companies. Dr Paul Janssen had only one objective: to improve the quality of life by developing better medicines. For this reason, Janssen Pharmaceutica joined the Johnson & Johnson group in 1961.

Today, Janssen Pharmaceutica is one of the most innovative pharmaceutical companies in the world. Our research and development centre develops products for a wide range of disease areas, such as mental disorders, neurological problems, infectious diseases, immunological disorders, cancer, and cardiovascular and metabolic conditions.